GB202011139D0 - Use of cannabidiol, in the treatment of seizures associated with rare epilepsy sundromes - Google Patents

Use of cannabidiol, in the treatment of seizures associated with rare epilepsy sundromes

Info

Publication number
GB202011139D0
GB202011139D0 GBGB2011139.9A GB202011139A GB202011139D0 GB 202011139 D0 GB202011139 D0 GB 202011139D0 GB 202011139 A GB202011139 A GB 202011139A GB 202011139 D0 GB202011139 D0 GB 202011139D0
Authority
GB
United Kingdom
Prior art keywords
sundromes
cannabidiol
treatment
seizures associated
epilepsy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2011139.9A
Other versions
GB2597295A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Research Ltd
Original Assignee
GW Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Research Ltd filed Critical GW Research Ltd
Priority to GB2011139.9A priority Critical patent/GB2597295A/en
Publication of GB202011139D0 publication Critical patent/GB202011139D0/en
Priority to PCT/EP2021/069812 priority patent/WO2022017914A1/en
Publication of GB2597295A publication Critical patent/GB2597295A/en
Pending legal-status Critical Current

Links

GB2011139.9A 2020-07-20 2020-07-20 Use of cannabidiol, in the treatment of seizures associated with rare epilepsy syndromes Pending GB2597295A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2011139.9A GB2597295A (en) 2020-07-20 2020-07-20 Use of cannabidiol, in the treatment of seizures associated with rare epilepsy syndromes
PCT/EP2021/069812 WO2022017914A1 (en) 2020-07-20 2021-07-15 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2011139.9A GB2597295A (en) 2020-07-20 2020-07-20 Use of cannabidiol, in the treatment of seizures associated with rare epilepsy syndromes

Publications (2)

Publication Number Publication Date
GB202011139D0 true GB202011139D0 (en) 2020-09-02
GB2597295A GB2597295A (en) 2022-01-26

Family

ID=72338895

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2011139.9A Pending GB2597295A (en) 2020-07-20 2020-07-20 Use of cannabidiol, in the treatment of seizures associated with rare epilepsy syndromes

Country Status (2)

Country Link
GB (1) GB2597295A (en)
WO (1) WO2022017914A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201806953D0 (en) * 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations
GB2581517A (en) * 2019-02-22 2020-08-26 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy

Also Published As

Publication number Publication date
WO2022017914A1 (en) 2022-01-27
GB2597295A (en) 2022-01-26

Similar Documents

Publication Publication Date Title
IL276217A (en) Use of cannabinoids in the treatment of epilepsy
IL285662A (en) Use of cannabinoids in the treatment of epilepsy
GB201819573D0 (en) Use of cannabinoids in the treatment of epilepsy
IL284758A (en) Use of cannabinoids in the treatment of comorbidities associated with epilepsy
MX2018002298A (en) Methods of using interleukin-10 for treating diseases and disorders.
GB202011139D0 (en) Use of cannabidiol, in the treatment of seizures associated with rare epilepsy sundromes
GB2590793B (en) Cannabidiol-C1 for use as a medicament and in the treatment of epilepsy
GB202011128D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes
GB202011154D0 (en) Use of cannabidiol in the treatment of seizures associated with encephaltis
GB202011126D0 (en) Use of cannabidiol in the treatment of sezures associated with mutifocal epilepsy
GB202011175D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011161D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202019301D0 (en) Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes
GB202011142D0 (en) Use of cannabidiol in the treatment of seizures associated with brain damage
GB202011149D0 (en) Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage
GB201915522D0 (en) Use of cannabidiol preparations in the treatment of absence epilepsy
GB202102010D0 (en) Use of cannabidivarin in the treatment of seizures associated with canine epilepsy
GB202108690D0 (en) Use of cannabinoids in the treatment of epilepsy
GB202014723D0 (en) Use of cannabinoids in the treatment of epilepsy
GB201915519D0 (en) Use of cannabidiol preparations in the treatment of temporal lobe epilepsy
GB202011143D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abbormalities of the brain
GB202011164D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy sydromes related to genetic abnormalities
GB202011122D0 (en) Use of cannabidiol in the treatment of seizures associated with auriculotemporal syndrome
GB202011150D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011140D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury